White matter hyperintensities associated with small vessel disease impair social cognition beside attention and memory

Journal of Cerebral Blood Flow and Metabolism

Volumn 38, Issue 6, 2018, Pages 996-1009

  Kynast, Jana ^a,b   Lampe, Leonie ^a,b   Luck, Tobias ^b,c   Frisch, Stefan ^a,b,d   Arelin, Katrin ^a,b   Hoffmann, Karl Titus ^b,c   Loeffler, Markus ^b   Riedel Heller, Steffi G ^b,c   Villringer, Arno ^a,b,c   Schroeter, Matthias L ^a,b,c  

^a MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Cognition; magnetic resonance imaging; small vessel disease; vascular cognitive impairment; white matter disease

Indexed keywords

ADULT; AGED; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FAZEKAS SCORE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERVIEW; LANGUAGE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SOCIAL COGNITION; TRAIL MAKING TEST; WHITE MATTER INJURY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; MEMORY; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULARIZATION; WHITE MATTER;

ADULT; AGED; ATTENTION; CEREBROVASCULAR DISORDERS; COGNITION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; WHITE MATTER;

EID: 85031097294     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X17719380     Document Type: Article

References (70)

1. Schaefer A, Quinque EM, Kipping JA, Early small vessel disease affects frontoparietal and cerebellar hubs in close correlation with clinical symptoms – a resting-state fMRI study. J Cereb Blood Flow Metab 2014; 34: 1091–1095.
2. Smith GE, Bondi MW. Mild cognitive impairment and dementia, Oxford: American Academy of Clinical Neuropsychology, 2013.
3. Stevens RD, Hannawi Y, Sair H. Small vessel disease and the resting functional architecture of the brain. J Cereb Blood Flow Metab 2014; 34: 1089–1090.
4. Pantoni L, Poggesi A, Inzitari D. The relation between white-matter lesions and cognition. Curr Opin Neurobiol 2007; 20: 390–397.
5. Frisoni GB, Galluzzi S, Pantoni L, The effect of white matter lesions on cognition in the elderly – small but detectable. Nature Clin Pract Neurol 2007; 3: 620–627.
6. Breteler MM. Vascular involvement in cognitive decline and dementia – epidemiologic evidence from the Rotterdam study and the Rotterdam scan study. Ann N Y Acad Sci 2006; 903: 457–465.
7. Habes M, Erus G, Toledo JB, White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain 2016; 139: 1164–1179.
8. Xiong YY, Mok V. Age-related white matter changes. J Aging Res 2011; 2011: 617927,.
9. Galluzzi S, Lanni C, Pantoni L, White matter lesions in the elderly: pathophysiological hypothesis on the effect on brain plasticity and reserve. J Neurol Sci 2008; 273: 3–9.
10. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341: c3666.
11. de Leeuw FE, de Groot JC, Achten E, Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatr 2001; 70: 9–14.
12. Kloppenborg RP, Nederkoorn PJ, Geerlings MI, Presence and progression of white matter hyperintensities and cognition – a meta-analysis. Neurology 2014; 82: 2127–2138.
13. Nichtweiss M, Weidauer S, Treusch N, White matter lesions and vascular cognitive impairment: part 1: typical and unusual causes. Clin Neuroradiol 2012; 22: 193–210.
14. Quinque EM, Arelin K, Dukart J, Identifying the neural correlates of executive functions in early cerebral microangiopathy: a combined VBM and DTI study. J Cereb Blood Flow Metab 2012; 32: 1869–1878.
15. Schmidt R, Grazer A, Enzinger C, MRI-detected white matter lesions: do they really matter? J Neural Transm 2011; 118: 673–681.
16. Schroeter ML, Bucheler MM, Preul C, Spontaneous slow hemodynamic oscillations are impaired in cerebral microangiopathy. J Cereb Blood Flow Metab 2007; 27: 1094–1094.
17. Schroeter ML, Cutini S, Wahl MM, Neurovascular coupling is impaired in cerebral micrangiopathy - An event-related Stroop study. NeuroImage 2007; 34(1): 26–34.
18. de Groot JC, de Leeuw FE, Oudkerk M, Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47: 145–151.
19. Maillard P, Carmichael O, Fletcher E, Coevolution of white matter hyperintensities and cognition in the elderly. Neurology 2012; 79: 442–448.
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
21. Fiske ST, Taylor SE. Social cognition – from brains to culture, London: Sage, 2013.
22. Baron-Cohen S, Bowen DC, Holt RJ, The “Reading the Mind in the Eyes” test: complete absence of typical sex difference in ∼400 men and women with Autism. PLoS One 2015; 10: e0136521.
23. Brune M, Brune-Cohrs U. Theory of mind – evolution, ontogeny, brain mechanisms and psychopathology. Neurosci Biobehav Rev 2006; 30: 437–455.
24. Schroeter M. Considering the frontomedian cortex in revised criteria for behavioural variant frontotemporal dementia. Brain 2012, pp. 135.
25. Schroeter ML, Laird AR, Chwiesko C, Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses – the case of behavioral variant frontotemporal dementia. Cortex 2014; 57: 22–37.
26. Premack D, Woodruff G. Chimpanzee problem-solving: a test for comprehension. Science 1978; 202: 532–535.
27. Ellis HD, Gunter HL. Asperger syndrome: a simple matter of white matter? TICS 1999; 3: 192–200.
28. Chisholm K, Lin A, Abu-Akel A, The association between autism and schizophrenia spectrum disorders: a review of eight alternate models of co-occurrence. Neurosci Biobehav Rev 2015; 55: 173–183.
29. Kana RK, Libero LE, Moore MS. Disrupted cortical connectivity theory as an explanatory model for autism spectrum disorders. Phys Life Rev 2011; 8: 410–437.
30. Kana RK, Libero LE, Hu CP, Functional brain networks and white matter underlying theory-of-mind in autism. SCAN 2014; 9: 98–105.
31. Cabinio M, Rossetto F, Blasi V, Mind-Reading ability and structural connectivity changes in aging. Front Psychol 2015; 6: 1808.
32. Charlton RA, Barrick TR, Markus HS, Theory of mind associations with other cognitive functions and brain imaging in normal aging. Psychol Aging 2009; 24: 338–348.
33. Mike A, Strammer E, Aradi M, Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study. PLoS One 2013; 8: e82422.
34. Baron-Cohen S, Wheelwright S, Hill J, The “Reading the Mind in the Eyes” Test revised version: a study with normal adults and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry 2001; 42: 241–251.
35. Bölte S. Reading the mind in the eyes test für Erwachsene (dt. Fassung) von S. Baron-Cohen. Frankfurt am Main: J.W. Goethe-Universität, 2005
36. Pardini M, Nichelli PF. Age-related decline in mentalizing skills across adult life span. Exp Aging Res 2009; 35: 98–106.
37. Baglio F, Castelli I, Alberoni M, Theory of mind in amnestic mild cognitive impairment: an fMRI study. J Alzheimers Dis 2012; 29: 25–37.
38. Kirkland RA, Peterson E, Baker CA, Metaanalysis reveals adult female superiority in “Reading the mind in the eyes” test. N Am J Psychol 2013; 15: 449–458.
39. Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry 2000; 15: 983–991.
40. de Groot JC, de Leeuw FE, Oudkerk M, Cerebral white matter lesions and subjective cognitive dysfunction. The Rotterdam Scan Study. Neurology 2001; 56: 1539–1545.
41. Haley AP, Hoth KF, Gunstad J, Subjective cognitive complaints relate to white matter hyperintensities and future cognitive decline in patients with cardiovascular disease. Am J Geriatr Psychiat 2009; 17: 976–985.
42. Benedictus MR, van Harten AC, Leeuwis AE, White matter hyperintensities relate to clinical progression in subjective cognitive decline. Stroke 2015; 46: 2661–2664.
43. Uiterwijk R, Huijts M, Staals J, Subjective cognitive failures in patients with hypertension are related to cognitive performance and cerebral microbleeds. Hypertension 2014; 64: 653–657.
44. Jorm AF, Butterworth P, Anstey KJ, Memory complaints in a community sample aged 60–64 years: associations with cognitive functioning, psychiatric symptoms, medical conditions, APOE genotype, hippocampus and amygdala volumes, and white-matter hyperintensities. Psychol Med 2004; 34: 1495.
45. Loeffler M, Engel C, Ahnert P, The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany. BMC Public Health 2015; 15: 691.
46. Fazekas F, Chawluk JB, Alavi A, MR signal abnormalities at 1.5-T in Alzheimers dementia and normal aging. Am J Neuroradiol 1987; 8: 421–426.
47. Gao FQ, Swartz RH, Scheltens P, Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study. J Alzheimers Dis 201126 Suppl 3, 379–388.
48. Scheltens P, Erkinjunti T, Leys D, White matter changes on CT and MRI: an overview of visual rating scales. Eur Neurol 1998; 39: 80–89.
49. Valdes Hernandez MC, Morris Z, Dickie DA, Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology 2013; 40: 13–22.
50. Beck IR, Schmid NS, Berres M, Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression. Int J Geriatr Psychiatry 2014; 29: 624–634.
51. Madureira S, Verdelho A, Ferro J, Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data. Neuroepidemiology 2006; 27: 101–116.
52. Henry LA, Messer DJ, Nash G. Executive functioning and verbal fluency in children with language difficulties. Learn Inst 2015; 39: 137–147.
53. van Boxtel MP, Buntinx F, Houx PJ, The relation between morbidity and cognitive performance in a normal aging population. J Gerontol Biol Sci Med Sci 1998; 53: M147–M154.
54. Mueller KD, Koscik RL, LaRue A, Verbal fluency and early memory decline: results from the Wisconsin Registry for Alzheimer's Prevention. Arch Clin Neuropsychol 2015; 30: 448–457.
55. Ahmed FS, Miller LS. Executive function mechanisms of theory of mind. J Autism Dev Disord 2011; 41: 667–678.
56. Peterson E, Miller S. The eyes test as a measure of individual differences: how much of the variance reflects verbal IQ? Front Psychol 2012; 3: 220.
57. Pinkham AE, Penn DL, Green MF, Social cognition psychometric evaluation: results of the initial psychometric study. Schizophr Bull 2014; 40: 813–823.
58. Wilson BA, Alderman N, Burgess PW, et al. Behavioural assessment of the dysexecutive syndrome (BADS). Bury St Edmunds, UK: Thames Valley Test Company Harcourt Assessment, 1996
59. Pedrero-Perez EJ, Ruiz-Sanchez-de-Leon JM, Winpenny-Tejedor C. Dysexecutive Questionnaire (DEX): unrestricted structural analysis in large clinical and non-clinical samples. Neuropsychol Rehabil 2015; 25: 879–894.
60. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J 2013; 34: 2159–219.
61. Bortz J, Lienert GA, Boehnke K. Verteilungsfreie methoden in der biostatistik, 3rd ed. Berlin, Heidelberg: Springer-Verlag, 2008.
62. Conover WJ. Practical nonparametric statistics, New York: Wiley, 1971.
63. Schaich E, Hamerle A. Verteilungsfreie statistische prüfverfahren, Berlin: Springer, 1984.
64. Durlak JA. How to select, calculate, and interpret effect sizes. J Pediatr Psychol 2009; 34: 917–928.
65. IBM Corp. IBM SPSS statistics for windows, version 22.0, Armonk, NY: IBM Corp, 2013.
66. Microsoft. Microsoft excel 2010, Redmond, WA: Microsoft, 2010.
67. Adobe Systems Incorporated. Adobe illustrator CS5, version 15.1.1, San Jose, CA: Adobe Systems, 2010.
68. Shiee N, Bazin P-L, Ozturk A. A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. Neuroimage 2010; 49: 1524–1535.
69. Kester MI, Goos JDC, Teunissen CE. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. JAMA Neurol 2014; 71: 855–862.
70. Mortamais M, Artero S, Ritchie K. White matter hyperintensities as early and independent predictors of Alzheimer's disease risk. J Alzheimers Dis 2014; 42: 393–400.